Claudia von Arx

6PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markersMolecular targetsChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 22, 2023
Neratinib as adjuvant therapy in patients with HER2 positive breast cancer: expert opinion.

Roberta Caputo, Giuseppe Buono, Vincenzo Di Lauro

|Apr 23, 2022
Male Breast Cancer: From Molecular Genetics to Clinical Management.

Matilde Pensabene, Claudia Von Arx, Michelino De Laurentiis

|Aug 25, 2019
Updates on the Role of Molecular Alterations and NOTCH Signalling in the Development of Neuroendocrine Neoplasms.

Claudia von Arx, Monica Capozzi, Elena López-Jiménez

|Aug 25, 2019
Safety and Activity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine Neoplasms.

Salvatore Tafuto, Claudia von Arx, Monica Capozzi

Pageof 1